Target intelligence / Profile preview

Metadherin pseudogene 3 (MTDHP3)

Target: MTDHP3
Molecular classification: Other (Pseudogene)

Overview

Metadherin pseudogene 3 (MTDHP3) is a transcribed pseudogene related to the metadherin (MTDH) gene. Unlike the functional MTDH/AEG-1 protein, which is widely studied for its roles in cancer biology and metastasis, there are no publications or data indicating that MTDHP3 codes for a functional protein, is a therapeutic target, or participates in any biological pathways or disease mechanisms. MTDHP3 is classified as a pseudogene and does not appear in the therapeutic or biomarker literature. Most information and relevance for drug discovery or therapeutics pertain to the canonical metadherin protein (MTDH/AEG-1) rather than MTDHP3.

Other names: Metadherin Pseudogene 3

Beyond the preview

Go deeper on Metadherin pseudogene 3 (MTDHP3).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Metadherin pseudogene 3 (MTDHP3).

Explore the full profile